X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (44874) 44874
Book Review (14243) 14243
Publication (4094) 4094
Newsletter (1309) 1309
Book Chapter (404) 404
Newspaper Article (304) 304
Conference Proceeding (218) 218
Magazine Article (145) 145
Book / eBook (71) 71
Transcript (51) 51
Trade Publication Article (17) 17
Dissertation (16) 16
Reference (6) 6
Web Resource (6) 6
Streaming Video (5) 5
Data Set (2) 2
Government Document (2) 2
Presentation (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (38547) 38547
index medicus (38476) 38476
female (17255) 17255
antibodies, monoclonal - therapeutic use (15132) 15132
male (12545) 12545
antibodies, monoclonal, humanized (12530) 12530
oncology (10642) 10642
animals (10362) 10362
middle aged (10336) 10336
antibodies, monoclonal, humanized - therapeutic use (10223) 10223
adult (8693) 8693
treatment outcome (8367) 8367
aged (7748) 7748
monoclonal antibodies (7568) 7568
cancer (6825) 6825
bevacizumab (6445) 6445
antineoplastic agents - therapeutic use (5781) 5781
immunology (5362) 5362
care and treatment (5229) 5229
monoclonal-antibody (5078) 5078
therapy (4934) 4934
mice (4874) 4874
antineoplastic combined chemotherapy protocols - therapeutic use (4838) 4838
pharmacology & pharmacy (4752) 4752
antibodies (4685) 4685
chemotherapy (4325) 4325
trastuzumab (4241) 4241
antibodies, monoclonal - administration & dosage (4111) 4111
research (4024) 4024
antibodies, monoclonal - adverse effects (3969) 3969
immunotherapy (3967) 3967
health aspects (3854) 3854
drug therapy (3787) 3787
angiogenesis inhibitors - therapeutic use (3751) 3751
antibodies, monoclonal, humanized - administration & dosage (3522) 3522
medicine & public health (3339) 3339
breast neoplasms - drug therapy (3321) 3321
analysis (3272) 3272
abridged index medicus (3156) 3156
antibodies, monoclonal, humanized - adverse effects (2951) 2951
aged, 80 and over (2867) 2867
adalimumab (2854) 2854
cetuximab (2756) 2756
proteins (2725) 2725
clinical trials as topic (2690) 2690
clinical trials (2666) 2666
antibodies, monoclonal - pharmacology (2640) 2640
expression (2618) 2618
retrospective studies (2584) 2584
double-blind (2582) 2582
breast cancer (2541) 2541
hematology (2541) 2541
viral antibodies (2428) 2428
infliximab (2414) 2414
tumors (2380) 2380
medicine, research & experimental (2377) 2377
article (2348) 2348
vascular endothelial growth factor a - antagonists & inhibitors (2250) 2250
rheumatology (2201) 2201
ophthalmology (2193) 2193
immunosuppressive agents - therapeutic use (2191) 2191
tumor necrosis factor-alpha - antagonists & inhibitors (2177) 2177
cell line, tumor (2155) 2155
efficacy (2146) 2146
antibodies, monoclonal - immunology (2135) 2135
safety (2090) 2090
prognosis (2061) 2061
antibody (2043) 2043
rituximab (2012) 2012
metastasis (1902) 1902
endothelial growth-factor (1891) 1891
young adult (1887) 1887
antirheumatic agents - therapeutic use (1872) 1872
biotechnology & applied microbiology (1856) 1856
trial (1853) 1853
immunoglobulins (1848) 1848
biological products (1846) 1846
breast neoplasms - pathology (1838) 1838
medical research (1800) 1800
surgery (1788) 1788
arthritis, rheumatoid - drug therapy (1783) 1783
risk factors (1782) 1782
follow-up studies (1776) 1776
adolescent (1767) 1767
transplantation (1754) 1754
disease-free survival (1736) 1736
colorectal neoplasms - drug therapy (1727) 1727
medicine, general & internal (1722) 1722
patients (1701) 1701
monoclonal antibody (1692) 1692
disease (1691) 1691
rheumatoid arthritis (1665) 1665
hematology, oncology and palliative medicine (1652) 1652
biochemistry & molecular biology (1634) 1634
rheumatoid-arthritis (1619) 1619
time factors (1617) 1617
monoclonal-antibodies (1608) 1608
immunoglobulin g - therapeutic use (1591) 1591
vascular endothelial growth factor (1591) 1591
internal medicine (1590) 1590
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (40) 40
Online Resources - Online (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Engineering & Comp. Sci. - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Gerstein Science - Circulation Desk (2) 2
UofT at Mississauga - Stacks (2) 2
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (44638) 44638
Japanese (685) 685
French (500) 500
German (383) 383
Spanish (243) 243
Chinese (150) 150
Hungarian (74) 74
Italian (67) 67
Russian (54) 54
Polish (40) 40
Czech (39) 39
Danish (39) 39
Dutch (31) 31
Portuguese (25) 25
Finnish (16) 16
Norwegian (13) 13
Romanian (13) 13
Swedish (13) 13
Hebrew (11) 11
Korean (11) 11
Croatian (9) 9
Slovak (4) 4
Serbian (3) 3
Turkish (3) 3
Icelandic (2) 2
Lithuanian (2) 2
Bosnian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 8, pp. 711 - 721
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, pp. e0137345 - e0137345
CD47 is a widely expressed cell surface protein that functions as a regulator of phagocytosis mediated by cells of the innate immune system, such as... 
TARGET | APOPTOSIS | STEM-CELLS | PROGNOSTIC-FACTOR | MACROPHAGES | MULTIDISCIPLINARY SCIENCES | REGULATORY PROTEIN-ALPHA | CD47 | PROMOTE PHAGOCYTOSIS | CANCER | SYNERGIZES | Phagocytosis - drug effects | Antibodies, Monoclonal, Humanized - therapeutic use | Antineoplastic Agents - immunology | Leukemia, Myeloid, Acute - pathology | Humans | Antibodies, Monoclonal - pharmacokinetics | Macaca fascicularis | Antibodies, Monoclonal - therapeutic use | Antibody Affinity | Antineoplastic Agents - therapeutic use | Leukemia, Myeloid, Acute - immunology | CD47 Antigen - immunology | Haplorhini | Rituximab - therapeutic use | Animals | Antibodies, Monoclonal, Humanized - pharmacokinetics | Leukemia, Myeloid, Acute - drug therapy | Female | Antineoplastic Agents - pharmacokinetics | Mice | Mice, Inbred BALB C | Tumor Cells, Cultured | Antibodies, Monoclonal, Humanized - immunology | Antibodies, Monoclonal - immunology | Monoclonal antibodies | Physiological aspects | Genetic aspects | Research | Non-Hodgkin's lymphomas | Drug therapy | Animal models | Leukemia | Immunoglobulin G | Xenotransplantation | Clinical trials | Stem cell transplantation | Biology | Macrophages | Cancer therapies | Cell surface | Proteins | Signal transduction | Allografts | Xenografts | Primates | Chemical bonds | Bone marrow | Chief executive officers | Drug dosages | Immune system | Medical research | Complementarity | Dendritic cells | Myeloid leukemia | Rituximab | Lymphoma | Immune systems | Medicine | Serum levels | Chemotherapy | Medical prognosis | Stem cells | Solid tumors | Acute myeloid leukemia | Phagocytosis | Cancer | Apoptosis | Tumors | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2016, Volume 374, Issue 21, pp. 2044 - 2053
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 908 - 918
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 16, pp. 1527 - 1539
Journal Article